Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
105.9 USD | -0.02% | -1.52% | -3.79% |
04-29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
04-26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.8B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B | |
-0.03% | 25B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Citigroup Adjusts Abbott Laboratories' Price Target to $125 From $154, Reiterates Buy Rating